Rantuss Drugs Private Limited
About Rantuss Drugs Private Limited
Data last updated:
Rantuss Drugs Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 June 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2012PTC081440.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Umamaheswara Rao Kotte and Ratna Kumari Kotti.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Mch No 7 – 1 – 643 Flat No 201 Bhanu Enclave Sundernagar Near Esi Hospital Erragadda, Hyderabad, Telangana, India – 500038.
Company details
CIN history
Rantuss Drugs has one previous CIN (Corporate Identification Number): U24230AP2012PTC081440. The current CIN is U24230TG2012PTC081440, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TG2012PTC081440 | Current |
| U24230AP2012PTC081440 | Previous |
Contact details
Rantuss Drugs Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressMch No 7 – 1 – 643 Flat No 201 Bhanu Enclave Sundernagar Near Esi Hospital Erragadda, Hyderabad, Telangana, India – 500038
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Rantuss Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Rantuss Drugs Private Limited
FY 2019 filings availableFinancial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rantuss Drugs Private Limited, buy the company report.
Board of directors of Rantuss Drugs Private Limited
Rantuss Drugs has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Umamaheswara Rao Kotte | Director | 13 Jun 2012 | 14 Years 4 Months | Current |
| Ratna Kumari Kotti Also directs: Rantus Pharma Private Limited | Director | 13 Jun 2012 | 14 Years 4 Months | Current |
Auditor
Rantuss Drugs Private Limited is audited by I R RAO & COMPANY for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| I R RAO & COMPANY | FY 2019 | 007523S |
Shareholding
The shareholding of Rantuss Drugs Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Rantuss Drugs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rantuss Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rantuss Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Rantuss Drugs Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Rantuss Drugs Private Limited has 4 board changes on record since 2012: 2 appointments and 2 cessations. The latest: Satyanarayana Reddy Chinnamail ceased to be Director on 16 Jun 2015.
Frequently asked questions
Rantuss Drugs is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 June 2012 (14+ years old) and is registered under CIN U24230TG2012PTC081440.
Rantuss Drugs has 2 current directors:
- Umamaheswara Rao Kotte - Director
- Ratna Kumari Kotti - Director
The latest financial statements of Rantuss Drugs on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Rantuss Drugs is U24230TG2012PTC081440. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rantuss Drugs was incorporated on 13 June 2012, making it 14+ years old. It is registered with the Registrar of Companies, Hyderabad.
Satyanarayana Reddy Chinnamail ceased to be Director on 16 Jun 2015. Sriramakrishna Durgaprasad Pratiwada ceased to be Director on 16 Jun 2015. Ratna Kumari Kotti was appointed as Director on 13 Jun 2012. Rantuss Drugs has 4 board changes on record in total.
The registered office of Rantuss Drugs is at Mch No 7 – 1 – 643 Flat No 201 Bhanu Enclave Sundernagar Near Esi Hospital Erragadda, Hyderabad, Telangana, India – 500038.
Rantuss Drugs operates in the pharma industry, in the drug formulation and development segment.
Rantuss Drugs can be reached at its registered office: Mch No 7 – 1 – 643 Flat No 201 Bhanu Enclave Sundernagar Near Esi Hospital Erragadda, Hyderabad, Telangana, India – 500038.
Rantuss Drugs is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
